Literature DB >> 16730131

Influence of [18F] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma.

Xiao-Kang Zheng1, Long-Hua Chen, Quan-Shi Wang, Fu-Bing Wu.   

Abstract

PURPOSE: The purpose of this study was to evaluate the role of [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) in influencing salvage treatment decision making for locally persistent nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS: A total of 33 NPC patients with histologic persistence at nasopharynx 1 to 6 weeks after a full course of radiotherapy underwent both computed tomography (CT) and FDG-PET/CT simulation at the same treatment position. The salvage treatment decisions, with regard to the decision to offer salvage treatment and the definition of gross tumor volume (GTV), were made before knowledge of the FDG-PET findings. Subsequently the salvage treatment decisions were made again based on the FDG-PET findings and compared with the pre-FDG-PET decisions.
RESULTS: All 33 patients were referred for salvage treatment in the pre-FDG-PET decision. After knowledge of the FDG-PET results, the decision to offer salvage treatment was withdrawn in 4 of 33 patients (12.1%), as no abnormal uptake of FDG was found at nasopharynx. Spontaneous remission was observed in repeat biopsies and no local recurrence was found in these 4 cases. For the remaining 29 patients, GTV based on FDG-PET was smaller than GTV based on CT in 24 (82.8%) cases and was greater in 5 (17.2%) cases, respectively. The target volume had to be significantly modified in 9 of 29 patients (31%), as GTV based on FDG-PET images failed to be enclosed by the treated volume in the salvage treatment plan performed based on GTV based on CT simulation images.
CONCLUSION: Use of FDG-PET was found to influence the salvage treatment decision making for locally persistent NPC by identifying patients who were not likely to benefit from additional treatment and by improving accuracy of GTV definition in salvage treatment planning.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730131     DOI: 10.1016/j.ijrobp.2006.02.037

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma.

Authors:  Miguel Pastor Borgoñón; Ricard Mesía Nin; Juan Jesús Cruz Hernández; Dolores Isla Casado
Journal:  Clin Transl Oncol       Date:  2010-11       Impact factor: 3.405

2.  SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013.

Authors:  R Mesía; M Pastor; J J Grau; E del Barco
Journal:  Clin Transl Oncol       Date:  2013-08-27       Impact factor: 3.405

3.  Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Hung-Ming Wang; Chin-Yu Lin; Kai-Ping Chang; Yu-Chun Lin
Journal:  Eur Radiol       Date:  2010-09       Impact factor: 5.315

4.  SEOM clinical guideline in nasopharynx cancer (2017).

Authors:  M Pastor; A Lopez Pousa; E Del Barco; P Perez Segura; B Gonzalez Astorga; B Castelo; T Bonfill; J Martinez Trufero; J Jose Grau; R Mesia
Journal:  Clin Transl Oncol       Date:  2017-11-02       Impact factor: 3.405

5.  Hopkins criteria for residual disease assessment after definitive radiotherapy in nasopharyngeal carcinoma.

Authors:  Yang Liu; Wen Long; Guannan Wang; Yuxiang Yang; Biaoshui Liu; Wei Fan
Journal:  Cancer Med       Date:  2019-12-25       Impact factor: 4.452

6.  The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging.

Authors:  Xiao Bao; Zhongyi Yang; Siyang Wang; Yujia Zheng; Mingwei Wang; Bingxin Gu; Jianping Zhang; Yongping Zhang; Yingjian Zhang
Journal:  Oncotarget       Date:  2016-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.